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Available online 16 October 2015Poikiloderma with neutropenia (PN, Clericuzio-type poikiloderma with neutropenia) is a rare autosomal reces-
sive disorder caused by biallelic mutations in the USB1 gene (Alias C16orf57 and MPN1). To date, there have
been only 37 reported casesworldwide of this disorder that presentswith neutropenia, early onset poikiloderma,
respiratory infections, palmo-plantar hyperkeratosis, and skeletal defects. Here we described the generation of
human induced pluripotent stem cell lines (PN1 and PN2) from the peripheral blood of a 1-year-old patient
using the dox-inducible STEMCCA vector. This patient presented with bacteremia, pneumonia, and neutropenia.
Analysis of bone marrow demonstrated normal cellularity with trilineage hematopoiesis and neutropenia.
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Peripheral blood mononuclear cells (PBMCs) were collected from a
patient carrying a mutation in USB1 (c.693+1GNT), transduced with
dox-inducible STEMCCA vectors overexpressing OCT4, SOX2, KLF4,
and cMYC.icle under the CC BY-NC-ND licenseThe mutation was validated in iPSCs by DNA sequencing and
cDNA ampliﬁcation of the truncated mRNA transcript. Veriﬁcation of
pluripotency was performed by ﬂow cytometry and qRT-PCR of
common undifferentiated markers.
G-banding was performed to verify normal 46, XX karyotype.
Teratoma analysis was performed to demonstrate all three embry-
onic germ layers.
1. Materials and methods
The recruitment of this human subject and iPSC generation for this
manuscript was approved by The Children's Hospital of Philadelphia's
IRB (IRB 09-007,042) and ethics committee. PBMCs were collected
from a patient with poikiloderma with neutropenia, harboring a muta-
tion in the C16ORF57 gene, and reprogrammed as previously described
(Colombo et al., 2012; Sommer et al., 2012). Brieﬂy, 5 × 10^5 PBMCs
were expanded in QBSF-60 media containing EPO (2 U/mL), IGF-1 (40
ng/mL), SCF (50 ng/mL), IL-3 (10 ng/mL), dexamethasone (1 μM),
ascorbic acid (50 ng/mL), glutamine (1%) and penicillin/streptomycin
(1%) for 7 days. Cells were transduced with a doxycycline-regulated
human STEMCCA lentivirus expressing OCT4, SOX2, KLF4 and cMYC.
After 24 h, 2 μg/mL of doxycycline (DOX) was added to the media
and cells were placed in culture dishes containing irradiated mouse
embryonic feeders (MEFs). At day 4 post-transduction, the media
was changed to human embryonic stem cell media (HES) containing
5 ng/mL of bFGF+ 2 μg/mL of DOX. Themedia was replenished every(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Analysis of iPSCs generated from a poikiloderma with neutropenia (PN) patient. A. Morphology of PN-iPSC colony. B. The splicing mutation affects the donor splice site of IVS6,
c693+1GNT, detected in the homozygous state and results in truncated cDNA. C. Representative ﬂow cytometry analysis plots of undifferentiated markers: SSEA3, SSEA4, TRA-1-60, TRA-1-
81. D. Quantitative PCR of relative gene expression of key pluripotency genes compared to ﬁbroblast and embryonic stem cell lines (CHB8 and H9), and transgene silencing in the absence of
doxycycline. E. Karyotype of PN-IPSCs derived from patient sample. F. Hematoxylin and eosin staining of teratoma sections demonstrating the potential for generation of all three germ layers.
596 J.A. Mills et al. / Stem Cell Research 15 (2015) 595–5972–3 days for 3 weeks. Cells were maintained in these conditions until
uniform colonies were generated, and iPSC colonies were mechani-
cally isolated and expanded on MEFs (Fig. 1A).
2. Mutation veriﬁcation.
Genomic DNA was isolated from iPSCs using a blood and tissue ex-
traction kit (Qiagen, Valencia, CA). About 50 ng of DNA was ampliﬁed
using Platinum PCR Supermix high ﬁdelity (Invitrogen) with primers:
Forward: CCTCCTTCCACAGATTCTTC and Reverse: GTTCCTCCATCTCAGCCTG, (Clericuzio et al., 2011) using thermocycler conditions: 95C for
10 min, 94C for 30 s and 60C for 15 s, and 72C for 30 s for 35 cycles,
then a 4C hold. Amplicons were sequenced, and electropherograms
were analyzed with the APE plasmid editor using the wild type
sequence of the C16orf57 gene [ENSG00000103005] as reference.
3. Flow cytometry
Analysis of cells was performed on a Cantos ﬂow cytometer (Becton
Dickinson, San Jose, CA). Human PN iPSCs were disassociated to single
597J.A. Mills et al. / Stem Cell Research 15 (2015) 595–597cells using Accutase and were analyzed for cell surface markers SSEA3-
488, SSEA4-647, Tra-1-60-PE and Tra-1-81-APC (Biolegend). Flow cyto-
metric analysis was performed using the FlowJo (Treestar, San Carlos,
CA) software program.
4. RT-PCR and quantitative PCR
Total RNA was collected using the RNeasy micro kit (Qiagen) and
treated with on-column RNase-free DNase. The ﬁrst strand synthesis
of cDNA was performed using 1 μg of total RNA, according to manufac-
tures speciﬁcation. RT-qPCR was performed on the LightCycler-480
(Roche-Genentech, South San Francisco, CA). All experiments were
performed in triplicate using SYBR-Green qPCR supermix (Life technol-
ogies, Grand Island, NY) according to manufacturer's instructions.
Primers for all genes were prepared by IDT (www.idt.dna.com), as
previously published (Mills et al., 2013). Dilutions of genomic DNA
were used as standards ranging from 1 ng to 100 ng/μl, and were used
to determine PCR efﬁciency and relative gene expression compared to
the housekeeping gene Cyclophilin G. Veriﬁcation of the truncated
transcript was performed using Platinum Blue Supermix, 50 ng of
cDNA and primers: Forward: CCTCCTTCCACAGATTCTTC, Reverse:
GTTCCTCCATCTCAGCCTG. PCR conditions: as above.
5. Teratoma formation
Teratoma assays were performed as previously described (Mills
et al., 2013). Brieﬂy, iPSCs (1× 10^6 cells)were injected subcutaneouslyinto the leg of a NOD/SCIDmouse. Tumor growth wasmonitored week-
ly by palpation. Animals were sacriﬁced when the tumor size was at
roughly 1 cm. The tumor was placed in 4% phosphate buffered formalin
for 24 h and then embedded in parafﬁn. For histological analysis, the
specimens were stained with hematoxylin and eosin (HE).
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